Compare AORT & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AORT | HROW |
|---|---|---|
| Founded | 1984 | 1998 |
| Country | United States | United States |
| Employees | 1800 | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 1996 | N/A |
| Metric | AORT | HROW |
|---|---|---|
| Price | $35.22 | $33.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | $48.76 | ★ $71.14 |
| AVG Volume (30 Days) | 320.7K | ★ 992.4K |
| Earning Date | 05-04-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.62 | N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $298,836,000.00 | N/A |
| Revenue This Year | $14.20 | $32.90 |
| Revenue Next Year | $11.17 | $48.52 |
| P/E Ratio | $173.14 | ★ N/A |
| Revenue Growth | ★ 18.01 | N/A |
| 52 Week Low | $21.97 | $20.85 |
| 52 Week High | $48.25 | $54.98 |
| Indicator | AORT | HROW |
|---|---|---|
| Relative Strength Index (RSI) | 36.98 | 34.70 |
| Support Level | $34.60 | $32.55 |
| Resistance Level | $38.42 | $41.49 |
| Average True Range (ATR) | 1.11 | 1.54 |
| MACD | 0.05 | 0.21 |
| Stochastic Oscillator | 10.32 | 19.45 |
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.